Ország: Írország
Nyelv: angol
Forrás: HPRA (Health Products Regulatory Authority)
TAMSULOSIN HYDROCHLORIDE
Kiron Pharmaceutica BV
TAMSULOSIN HYDROCHLORIDE
400 Microgram
Capsules Modified Release
Authorised
0000-00-00
Common Technical Document Tamsulosin hydrochloride 0.4 mg capsules SynthonBV page 1/7 issue date: 06-03-2014 version: M1.3.1_03.TSL.hcl.mrc.037.06.IE.1621.01.wd 1.3.1 Package Leaflet PACKAGE LEAFLET: INFORMATION FOR THE USER TACAP 400 MICROGRAMS, MODIFIED-RELEASE CAPSULE, HARD Tamsulosin hydrochloride READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist . This includes any possible side effects not listed in this leaflet. See section 4. IN THIS LEAFLET: 1. What Tacap 400 micrograms is and what it is used for 2. What you need to know before you take Tacap 400 micrograms 3. How to take Tacap 400 micrograms 4. Possible side effects 5. How to store Tacap 400 micrograms 6. Contents of the pack and other information 1. WHAT TACAP 400 MICROGRAMS IS AND WHAT IT IS USED FOR Tamsulosin is an alpha 1A -adrenoreceptor blocker. It relaxes the muscles in the prostate and urinary tract. Tamsulosin is prescribed to alleviate urinary symptoms caused by an enlarged prostrate (benign prostatic hyperplasia). By relaxing the muscle it enables a more easily pass of urine and helps urination. 2. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE TACAP 400 MICROGRAMS DO NOT TAKE TACAP 400 MICROGRAMS IF YOU: Common Technical Document Tamsulosin hydrochloride 0.4 mg capsules Sy Olvassa el a teljes dokumentumot
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Tacap 400 micrograms Modified-release Capsules, hard 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each capsule contains as active ingredient tamsulosin hydrochloride 0.4 mg. For a full list of excipients, see Section 6.1 3 PHARMACEUTICAL FORM Modified-release capsule, hard. Orange/olive-green capsule (19.3 x 6.4 mm). The capsules contain white to off-white pellets. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Oral use Posology No dose adjustment is warranted in renal impairment. No dose adjustment is warranted in patients with mild to moderate hepatic insufficiency (see also 4.3 Contraindications). _Paediatric population_ There is no relevant indication for use of tamsulosin in children. The safety and efficacy of tamsulosine in children < 18 years have not been established. Currently available data are described in section 5.1. Method of administration One capsule daily, to be taken after breakfast or the first meal of the day. The capsule must be swallowed whole and must not be crunched or chewed, as this interferes with the modified release of the active ingredient. 4.3 CONTRAINDICATIONS Hypersensitivity to the active substance, including drug-induced angio-oedema, or to any of the excipients listed in section 6.1. A history of orthostatic hypotension. Severe hepatic insufficiency. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 07/04/2014_ _CRN 2140709_ _page number: 1_ 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE As with other 1-adrenoceptors antagonists, a reduction in blood pressure can occur in indivi Olvassa el a teljes dokumentumot